Which products did Anvisa order recalled?

Brazil's health regulator Anvisa has issued a mandatory recall order for a range of irregular medical products currently on the market. The items in question were manufactured in Spain and Italy and registered in Brazil by three companies: Adium, Biohealth, and Grossmed.

Why were these products suspended?

Anvisa classified the products as irregular, meaning they do not comply with Brazilian health regulations. When a product fails to meet the required standards, the regulator can order its immediate suspension and removal from shelves to protect consumers and patients.

What should consumers and health professionals do?

Anyone who has purchased or is currently using products registered by Adium, Biohealth, or Grossmed should check whether their item appears on the official Anvisa recall list. Health professionals, pharmacies, clinics, and distributors are required to stop selling and using the affected products immediately and follow the official return or disposal procedures outlined by Anvisa.

How does Anvisa handle recalled products?

Once a recall order is issued, companies are legally obligated to retrieve the products from the supply chain. Anvisa monitors compliance and can apply penalties to companies that fail to act. Consumers who have been harmed by irregular medical products can also file a complaint directly with the regulator through its official channels.

Key Facts:
  • Anvisa ordered the mandatory recall of irregular medical products.
  • The suspended products were manufactured in Spain and Italy.
  • Three companies are involved: Adium, Biohealth, and Grossmed.
  • Consumers should check the official Anvisa list to see if their products are affected.
  • Distributors, pharmacies, and clinics must halt sales immediately.